Tweaking the immune system: Gene therapy-assisted autologous haematopoietic stem cell transplantation as a treatment for autoimmune disease

Autoimmunity

Volumn 41, Issue 8, 2008, Pages 679-685

  Alderuccio, Frank ^a   Chan, James ^a   Toh, Ban Hock ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Animal models; Autoimmunity; Gene therapy; Hematopoietic stem cell transplantation; Immune tolerance

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN ASSOCIATED GLYCOPROTEIN; PHOSPHOLIPID PROTEIN; PROINSULIN; PROINSULIN 2; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; DENDRITIC CELL; GENETIC MANIPULATION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; STEM CELL GENE THERAPY; T CELL DEPLETION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; AUTOIMMUNE DISEASES; GENE THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE;

EID: 65449170736     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930802197123     Document Type: Review

References (53)

1. Janeway Jr., CA and Medzhitov, R. (2002) Innate immune recognition. Annu Rev Immunol, 20, pp. 197-216.
2. Diamond, B. (2005) Autoimmunity. Immunol Rev, 204, pp. 5-8.
3. Hogquist, KA, Baldwin, TA and Jameson, SC (2005) Central tolerance: Learning self-control in the thymus. Nat Rev Immunol, 5:10, pp. 772-782.
4. von Boehmer, H. (2005) Mechanisms of suppression by suppressor T cells. Nat Immunol, 6:4, pp. 338-344.
5. Miyara, M. and Sakaguchi, S. (2007) Natural regulatory T cells: Mechanisms of suppression. Trends Mol Med, 13:3, pp. 108-116.
6. Yamaguchi, T., Hirota, K. Nagahama, K. et al. (2007) Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity, 27:1, pp. 145-159.
7. Deaglio, S., Dwyer, KM Gao, W. et al. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med, 204:6, pp. 1257-1265.
8. McHugh, RS and Shevach, EM (2002) The role of suppressor T cells in regulation of immune responses. J Allergy Clin Immunol, 110:5, pp. 693-702.
9. Randolph, DA and Fathman, CG (2006) Cd4+Cd25+ regulatory T cells and their therapeutic potential. Annu Rev Med, 57, pp. 381-402.
10. Kyewski, B. and Derbinski, J. (2004) Self-representation in the thymus: An extended view. Nat Rev Immunol, 4:9, pp. 688-698.
11. Kyewski, B. and Klein, L. (2006) A central role for central tolerance. Annu Rev Immunol, 24, pp. 571-606.
12. Cheng, MH, Shum, AK and Anderson, MS (2007) What's new in the Aire?. Trends Immunol, 28:7, pp. 321-327.
13. Mathis, D. and Benoist, C. (2007) A decade of AIRE. Nat Rev Immunol, 7:8, pp. 645-650.
14. Bjorses, P., Aaltonen, J. Horelli-Kuitunen, N. et al. (1998) Gene defect behind APECED: A new clue to autoimmunity. Hum Mol Genet, 7:10, pp. 1547-1553.
15. Peterson, P., Nagamine, K. Scott, H. et al. (1998) APECED: A monogenic autoimmune disease providing new clues to self-tolerance. Immunol Today, 19:9, pp. 384-386.
16. Anderson, MS, Venanzi, ES Klein, L. et al. (2002) Projection of an immunological self shadow within the thymus by the Aire protein. Science, 298:5597, pp. 1395-1401.
17. Klamp, T., Sahin, U. Kyewski, B. et al. (2006) Expression profiling of autoimmune regulator AIRE mRNA in a comprehensive set of human normal and neoplastic tissues. Immunol Lett, 106:2, pp. 172-179.
18. Kogawa, K., Nagafuchi, S. Katsuta, H. et al. (2002) Expression of AIRE gene in peripheral monocyte/dendritic cell lineage. Immunol Lett, 80:3, pp. 195-198.
19. Lee, JW, Epardaud, M. Sun, J. et al. (2007) Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat Immunol, 8:2, pp. 181-190.
20. Liston, A., Lesage, S. Wilson, J. et al. (2003) Aire regulates negative selection of organ-specific T cells. Nat Immunol, 4:4, pp. 350-354.
21. Liston, A., Gray, DH Lesage, S. et al. (2004) Gene dosage-limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J Exp Med, 200:8, pp. 1015-1026.
22. Kont, V., Laan, M. Kisand, K. et al. (2008) Modulation of Aire regulates the expression of tissue-restricted antigens. Mol Immunol, 45:1, pp. 25-33.
23. Taubert, R., Schwendemann, J. and Kyewski, B. (2007) Highly variable expression of tissue-restricted self-antigens in human thymus: Implications for self-tolerance and autoimmunity. Eur J Immunol, 37:3, pp. 838-848.
24. Alderuccio, F., Toh, BH Tan, SS et al. (1993) An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus. J Exp Med, 178:2, pp. 419-426.
25. French, MB, Allison, J. Cram, DS et al. (1997) Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes, 46:1, pp. 34-39.
26. Jaeckel, E., Lipes, MA and von Boehmer, H. (2004) Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat Immunol, 5:10, pp. 1028-1035.
27. Xu, H., Wawrousek, EF Redmond, TM et al. (2000) Transgenic expression of an immunologically privileged retinal antigen extraocularly enhances self tolerance and abrogates susceptibility to autoimmune uveitis. Eur J Immunol, 30:1, pp. 272-278.
28. Murphy, K., Biondo, M., Toh, BH and Alderuccio, F. (2003) Tolerance established in autoimmune disease by mating or bone marrow transplantation that target autoantigen to thymus. Int Immunol, 15:2, pp. 269-277.
29. Steptoe, RJ, Ritchie, JM and Harrison, LC (2003) Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes. J Clin Invest, 111:9, pp. 1357-1363.
30. Billingham, RE, Brent, L. and Medawar, PB (1953) Actively acquired tolerance of foreign cells. Nature, 172:4379, pp. 603-606.
31. Brocker, T., Riedinger, M. and Karjalainen, K. (1997) Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med, 185:3, pp. 541-550.
32. Gallegos, AM and Bevan, MJ (2006) Central tolerance: Good but imperfect. Immunol Rev, 209, pp. 290-296.
33. Palmer, E. (2003) Negative selection-clearing out the bad apples from the T-cell repertoire. Nat Rev Immunol, 3:5, pp. 383-391.
34. Yamazaki, S., Inaba, K., Tarbell, KV and Steinman, RM (2006) Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. Immunol Rev, 212, pp. 314-329.
35. Yamazaki, S., Patel, M. Harper, A. et al. (2006) Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci USA, 103:8, pp. 2758-2763.
36. van Laar, JM and Tyndall, A. (2006) Adult stem cells in the treatment of autoimmune diseases. Rheumatology (Oxford), 45:10, pp. 1187-1193.
37. Dazzi, F., van Laar, JM, Cope, A. and Tyndall, A. (2007) Cell therapy for autoimmune diseases. Arthritis Res Ther, 9:2, p. 206.
38. Sykes, M. and Nikolic, B. (2005) Treatment of severe autoimmune disease by stem-cell transplantation. Nature, 435:7042, pp. 620-627.
39. Nash, RA, McSweeney, PA Crofford, LJ et al. (2007) High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: Long-term follow-up of the US multicenter pilot study. Blood, 110:4, pp. 1388-1396.
40. Alderuccio, F., Murphy, K. and Toh, BH (2003) Stem cells engineered to express self-antigen to treat autoimmunity. Trends Immunol, 24:4, pp. 176-180.
41. Siatskas, C., Chan, J. Field, J. et al. (2006) Gene therapy strategies towards immune tolerance to treat the autoimmune diseases. Curr Gene Ther, 6:1, pp. 45-58.
42. Ally, BA, Hawley, TS McKall-Faienza, KJ et al. (1995) Prevention of autoimmune disease by retroviral-mediated gene therapy. J Immunol, 155:11, pp. 5404-5408.
43. Bagley, J., Tian, C., Sachs, DH and Iacomini, J. (2002) Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy. Blood, 99:12, pp. 4394-4399.
44. Tian, C., Bagley, J. Cretin, N. et al. (2004) Prevention of type 1 diabetes by gene therapy. J Clin Invest, 114:7, pp. 969-978.
45. Tian, C., Bagley, J. and Iacomini, J. (2006) Persistence of antigen is required to maintain transplantation tolerance induced by genetic modification of bone marrow stem cells. Am J Transplant, 6:9, pp. 2202-2207.
46. Bonilla, WV, Geuking, MB Aichele, P. et al. (2006) Microchimerism maintains deletion of the donor cell-specific CD8+T cell repertoire. J Clin Invest, 116:1, pp. 156-162.
47. Chan, J., Clements, W. Field, J. et al. (2006) Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice. J Gene Med, 8:11, pp. 1281-1290.
48. Xu, B., Haviernik, P. Wolfraim, LA et al. (2006) Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE. Mol Ther, 13:1, pp. 42-48.
49. Kang, ES and Iacomini, J. (2002) Induction of central deletional T cell tolerance by gene therapy. J Immunol, 169:4, pp. 1930-1935.
50. Forman, D., Kang, ES Tian, C. et al. (2006) Induction of alloreactive CD4 T cell tolerance in molecular chimeras: A possible role for regulatory T cells. J Immunol, 176:6, pp. 3410-3416.
51. Tian, C., Bagley, J. and Iacomini, J. (2007) Homeostatic expansion permits T cells to re-enter the thymus and deliver antigen in a tolerogenic fashion. Am J Transplant, 7:8, pp. 1934-1941.
52. Berns, A. (2004) Good news for gene therapy. N Engl J Med, 350:16, pp. 1679-1680.
53. Hacein-Bey-Abina, S., von Kalle, C. Schmidt, M. et al. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med, 348:3, pp. 255-256.